Annuncio • Feb 13
BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million. BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 500,000,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Transaction Features: Subsequent Direct Listing Annuncio • Feb 05
BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million. BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 500,000,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Transaction Features: Subsequent Direct Listing Board Change • Jan 05
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Paul Stephenson is the most experienced director on the board, commencing their role in 2020. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Recent Insider Transactions • Dec 03
MD & Executive Director recently bought AU$180k worth of stock On the 27th of November, Matthew Leonard bought around 90m shares on-market at roughly AU$0.002 per share. This transaction increased Matthew's direct individual holding by 3x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Matthew's only on-market trade for the last 12 months. Reported Earnings • Oct 06
Full year 2025 earnings released: AU$0.003 loss per share (vs AU$0.006 loss in FY 2024) Full year 2025 results: AU$0.003 loss per share (improved from AU$0.006 loss in FY 2024). Revenue: AU$352.4k (up 220% from FY 2024). Net loss: AU$1.49m (loss narrowed 25% from FY 2024). Annuncio • Sep 19
BPH Global Ltd, Annual General Meeting, Nov 14, 2025 BPH Global Ltd, Annual General Meeting, Nov 14, 2025. Annuncio • Sep 17
BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million. BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.5501 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 250,000,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 50,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 25,000,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Reported Earnings • Aug 31
Full year 2025 earnings released: AU$0.002 loss per share (vs AU$0.006 loss in FY 2024) Full year 2025 results: AU$0.002 loss per share (improved from AU$0.006 loss in FY 2024). Revenue: AU$287.8k (up 162% from FY 2024). Net loss: AU$1.31m (loss narrowed 34% from FY 2024). Annuncio • May 02
BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million. BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.609 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 304,500,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Annuncio • Apr 28
BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million. BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.609 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 304,500,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing New Risk • Mar 26
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 56% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$826k free cash flow). Share price has been highly volatile over the past 3 months (55% average weekly change). Negative equity (-AU$1.7m). Earnings have declined by 3.1% per year over the past 5 years. Shareholders have been substantially diluted in the past year (56% increase in shares outstanding). Revenue is less than US$1m (AU$161k revenue, or US$101k). Market cap is less than US$10m (AU$2.43m market cap, or US$1.53m). New Risk • Mar 07
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$826k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$826k free cash flow). Share price has been highly volatile over the past 3 months (50% average weekly change). Negative equity (-AU$1.7m). Earnings have declined by 3.6% per year over the past 5 years. Revenue is less than US$1m (AU$161k revenue, or US$102k). Market cap is less than US$10m (AU$1.93m market cap, or US$1.22m). Minor Risk Shareholders have been diluted in the past year (24% increase in shares outstanding). New Risk • Jan 28
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 32% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (44% average weekly change). Negative equity (-AU$1.4m). Earnings have declined by 12% per year over the past 5 years. Shareholders have been substantially diluted in the past year (32% increase in shares outstanding). Revenue is less than US$1m (AU$110k revenue, or US$69k). Market cap is less than US$10m (AU$1.45m market cap, or US$912.0k). Annuncio • Dec 31
BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million. BPH Global Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.125 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 41,666,667
Price\Range: AUD 0.003
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Annuncio • Dec 18
BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.1 million. BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 33,333,334
Price\Range: AUD 0.003
Discount Per Security: AUD 0.00018
Transaction Features: Subsequent Direct Listing Annuncio • Dec 17
BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million. BPH Global Ltd has filed a Follow-on Equity Offering in the amount of AUD 0.125 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 41,666,667
Price\Range: AUD 0.003
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Reported Earnings • Oct 03
Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.016 loss in FY 2023) Full year 2024 results: AU$0.006 loss per share (improved from AU$0.016 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.98m (loss narrowed 49% from FY 2023). Annuncio • Oct 02
BPH Global Ltd, Annual General Meeting, Nov 27, 2024 BPH Global Ltd, Annual General Meeting, Nov 27, 2024. Reported Earnings • Aug 31
Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.018 loss in FY 2023) Full year 2024 results: AU$0.001 loss per share (improved from AU$0.018 loss in FY 2023). Revenue: AU$110.0k (up AU$109.6k from FY 2023). Net loss: AU$1.60m (loss narrowed 63% from FY 2023). New Risk • Jul 31
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.5m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Negative equity (-AU$244k). Earnings have declined by 19% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (AU$1.19m market cap, or US$772.7k). Annuncio • Apr 11
BPH Global Ltd. Announces Executive Changes BPH Global Limited announced the appointment of Justyn Stedwell as Company Secretary. Justyn has over 17 years' experience as a Company Secretary of ASX listed companies and has also served as a Non-Executive Director on several ASX listed company Boards. He holds a Bachelor of Commerce from Monash University, a Graduate Diploma of Accounting from Deakin University and Graduate Diploma in Applied Corporate Governance from the Governance Institute of Australia. Further to this appointment, Belinda Cleminson and Shelby Coleman have resigned as joint CompanySecretaries. New Risk • Mar 01
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$1.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.5m free cash flow). Share price has been highly volatile over the past 3 months (63% average weekly change). Negative equity (-AU$244k). Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (72% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (AU$3.91m market cap, or US$2.54m). Annuncio • Jan 18
BPH Global Ltd Announces Change of Joint Company Secretary BPH Global Ltd. announced that Shelby Coleman has been appointed as Joint Company Secretary, effective immediately. Ms Coleman holds a Bachelor of Laws and a Bachelor of Arts from Victoria University of Wellington.She is experienced in ASX and ASIC compliance, providing advice on corporate governance and compliance issues as well as other regulatory maters. As a member of Automic Group's Company Secretary team, Ms Coleman assists a number of ASX listed, unlisted public and proprietary companies across a range of industries. Further to this appointment, Ms Elizabeth Spooner will step down as Joint Company Secretary effecve immediately. Ms Belinda Cleminson of Automic Group will continue in her role, being Joint Company Secretary. New Risk • Dec 22
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 51% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (70% average weekly change). Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (51% increase in shares outstanding). Revenue is less than US$1m (AU$339 revenue, or US$231). Market cap is less than US$10m (AU$2.57m market cap, or US$1.75m). Annuncio • Dec 12
BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners. BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global Ltd (ASX:BP8) entered into an agreement to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners on September 20, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023. As of October 20, 2023, Completion of the acquisition is anticipated to occur 2 business days following the Company’s AGM on 21 November 2023 where shareholder approval for the issuance of shares to the vendors is being sought.BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners on December 11, 2023. Annuncio • Nov 22
BPH Global Ltd. Appoints Mathew Leonard as Managing Director BPH Global Ltd. announced that Mr. Mathew Leonard has been appointed as Managing Director. Board Change • Nov 06
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 4 experienced directors. 1 highly experienced director. 1 independent director (4 non-independent directors). Director Philip Gu is the most experienced director on the board, commencing their role in 2015. Independent Non-Executive Chairman Paul Stephenson was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Annuncio • Oct 20
BPH Global Ltd, Annual General Meeting, Nov 21, 2023 BPH Global Ltd, Annual General Meeting, Nov 21, 2023, at 16:00 AUS Eastern Standard Time. Location: at Automic offices at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To consider the Adoption of Remuneration Report; To consider the Election of Yanhua Huang as Director; To consider the Re-election of Huan Qing Gu as Director; To consider the ASX Listing Rule 7.1A Approval of Future Issue of Securities; To consider the Ratification of Prior Issue of Placement Shares; To consider the Approval of Issue of Placement Options; To consider the Approval of Issue of Options to Sanlam Private Wealth Pty Ltd; To consider the Approval of Issue of Shares and Options on conversion of 368,750 Convertible Notes; To consider the Approval of Issue of Shares and Options to Mr Paul Stephenson, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Francesco Cannavo, Director of the Company; To consider the Approval of Issue of Shares and Options to Mr Matthew Leonard, Director of the Company; and to consider other matters if any. Reported Earnings • Oct 05
Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in FY 2022) Full year 2023 results: AU$0.004 loss per share (improved from AU$0.005 loss in FY 2022). Net loss: AU$4.26m (loss narrowed 20% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings. Annuncio • Sep 21
BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million. BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023. Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022) Full year 2023 results: AU$0.003 loss per share. Net loss: AU$3.75m (loss widened 1.7% from FY 2022). New Risk • Aug 31
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.7m free cash flow). Share price has been highly volatile over the past 3 months (44% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (AU$3.27m market cap, or US$2.12m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (16% increase in shares outstanding). Annuncio • Jul 06
BPH Global Ltd Appoints Michael Huang as Non-Executive Director The Board of BPH Global Ltd. advised the appointment of Michael (Yanhua) Huang to the Board of Directors of the Company as a Non-Executive Director. Michael's return to the Board of BP8, marks a further consolidation of the Company' strategy to reinvigorate and further develop its bird's nest and dendrobium-infused bird's nest sales business in China (Bird's Nest Business). Michael Huang took the lead role on behalf of BP8 in conducting the pilot program in January and February this year. The pilot program trialled supply and distribution channels for the sale of bird's nest products via China Tobacco's outlets in Guangzhou and via social media influencers on Douyin, the China version of TikTok. Michael Huang brings his extensive experience and personal network in sales and marketing to the Board. Annuncio • May 12
Stemcell United Limited Announces Board Changes Stemcell United Limited advised that Mr. Paul Rosen has tendered his resignation as a Non-Executive Director and Chairman, effective 12 May 2023.The Company announced the appointment of Mr. Paul Stephenson as independent non-executive Chair of the Board, effective immediately. Annuncio • May 10
Stemcell United Limited, Annual General Meeting, Jun 09, 2023 Stemcell United Limited, Annual General Meeting, Jun 09, 2023, at 12:00 E. Australia Standard Time. Location: Suite 5, Level 12, 530 Collins Street Melbourne Victoria Australia Agenda: To consider the ratification of prior issue of securities; to consider the issue of placement options; to consider the issue of options to Sanlam Private Wealth Pty Ltd; to consider the issue of shares and options to directors; to consider the issue of shares to Sophisticated Investors; to consider the election of directors; and to consider the Change of Company Name. Board Change • Mar 31
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Director Matthew Leonard was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 